Introduction
The title poses a highly relevant question, as the Trump administration’s focus on declaring fentanyl a “weapon of mass destruction” seems incomplete. This new designation centers on border security and potential military action against international drug trafficking.
The New Designation: Focus and Limitations
This new classification does not enhance domestic law enforcement surveillance or address the street-level distribution of fentanyl. Consequently, the Department of Defense must now develop a strategy to prevent fentanyl from reaching the United States, as it is already present within the country.
The issue lies in the skewed approach, as fentanyl is likened to chemical, biological, and nuclear weapons. However, Trump overlooked the necessity for direct internal operations to combat fentanyl’s impact on American lives.
The Real Problem: Internal Distribution
Trump’s focus on fentanyl’s origins and international trafficking overlooks the fact that the drug is already active within the US. The real challenge lies in addressing demand and distribution on American streets, where cartels conduct their sales.
Critics argue that Trump’s strategy is misguided, as it excessively blames external actors like cartels and foreign countries while neglecting internal distribution networks.
Previous Actions and Oversights
In 2018, Trump’s administration approved measures to tackle fentanyl consumption domestically. However, Trump seems to have forgotten his own actions.
Trump overlooks the SUPPORT Act of 2018, which aimed to combat drug trafficking through treatment, prevention, and demand reduction. He also disregards the 2018 declaration of an opioid crisis as a national public health emergency and the establishment of the President’s Commission on Combating Drug Addiction and the Opioid Crisis.
Trump’s negligence of these initiatives and his focus on external threats, rather than addressing the root causes of drug addiction and demand, raises concerns about his commitment to solving the fentanyl crisis.
Conclusion
Trump’s “weapon of mass destruction” declaration appears to be a political maneuver for increased border security and international pressure, rather than addressing the real challenges of fentanyl distribution and addiction within the US.
While external sources of fentanyl precursors are a concern, the primary issue remains internal distribution and addiction. Trump’s strategy, which lacks focus on domestic solutions, may inadvertently benefit drug cartels by diverting attention from the real problem.
